WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000025813) CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/025813    International Application No.:    PCT/US1999/025438
Publication Date: 11.05.2000 International Filing Date: 29.10.1999
Chapter 2 Demand Filed:    26.05.2000    
IPC:
A61K 39/00 (2006.01), A61P 35/00 (2006.01), C12N 5/0784 (2010.01), A61K 35/12 (2006.01)
Applicants: DANA-FARBER CANCER INSTITUTE [US/US]; 44 Binney Street Boston, MA 02115 (US) (For All Designated States Except US).
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH [US/US]; 9 Cambridge Center Cambridge, MA 02142 (US) (For All Designated States Except US).
NADLER, Lee, M. [US/US]; (US) (For US Only).
HAHN, William, C. [US/US]; (US) (For US Only).
SCHULTZE, Joachim, L. [DE/US]; (US) (For US Only).
VONDERHEIDE, Robert, H. [US/US]; (US) (For US Only)
Inventors: NADLER, Lee, M.; (US).
HAHN, William, C.; (US).
SCHULTZE, Joachim, L.; (US).
VONDERHEIDE, Robert, H.; (US)
Agent: CLARK, Paul, T.; Clark & Elbing LLP 176 Federal Street Boston, MA 02110-2214 (US)
Priority Data:
60/106,106 29.10.1998 US
Title (EN) CANCER IMMUNOTHERAPHY AND DIAGNOSIS USING UNIVERSAL TUMOR ASSOCIATED ANTIGENS, INCLUDING hTERT
(FR) IMMUNOTHERAPIE ET DIAGNOSTIC DU CANCER AU MOYEN D'ANTIGENES UNIVERSELS ASSOCIES A DES TUMEURS TELS QUE hTERT
Abstract: front page image
(EN)The invention provides methods for conducting cancer immonotherapy and diagnosis using universal tumor associated antigens, such as the telomerase catalytic subunit (hTERT), and methods for identifying and characterizing universal tumor associated antigens.
(FR)Cette invention concerne des méthodes d'immunothérapie et de diagnostic au moyen d'antigènes associés à des tumeurs, tels que la sous-unité catalytique de la télomérase (hTERT), ainsi que des procédés permettant d'identifier et de caractériser des antigènes associés à des tumeurs.
Designated States: AU, CA, JP, US.
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)